Article thumbnail
Location of Repository

Are N-of-1 trials an economically viable option to improve access to selected high cost medications? The Australian experience

By Paul Scuffham, Michael Yelland, Jane Nikles, Eva Pietrzak and David Wilkinson


Griffith Health, School of MedicineFull Tex

Publisher: Blackwell Publishing
Year: 2008
DOI identifier: 10.1111/j.1524-4733.2007.00218.x
OAI identifier:

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.